Biotech companies have a crucial role in the society and will have to keep the quality and affordability of medicines in mind. India is amongst the top 12 biotech destinations in the world and second in Asia, after China. I am glad that the state of Andhra Pradesh has emerged as the undisputed leader in the country for Biotechnology and BioAsia has been a great platform helping the Government in attracting new investments into the state and showcasing the strengths of Genome Valley to the global community. I take this opportunity to assure continued support from the Government to the development of sector.
- Shri. N Kiran Kumar Reddy, Hon’ble Chief Minister of Andhra Pradesh, India - (@BioAsia 2012)
I am pleased to congratulate the organizers on the outcome of the successful Biotechnology International Fair – BioAsia held between February 17th and 19th, 2014. Moreover, I take this opportunity to highlight the space for dialogue and networking promoted by such fair in order to seek innovation in the industrial sector through the convergence of the main stakeholders in the sector, which will allow the promotion of the value added products and technological development. In this framework, it is worth mentioning that this Ministry prioritizes international cooperation in the sector of biotechnology to provide joint solutions to the main challenges posed by the increase of population in the production of food, energy and health. Please accept, the assurances of my highest consideration.
-- Dr. Lino Baranao, Hon'ble Minister of Science & Technology, Ministry of Science, Technology and Productive Innovation, Argentina - (@BioAsia 2014)
I’d like to take this opportunity to express my appreciation for the warm hospitality shown to Gangwon delegation visiting Hyderabad to discuss about the economic cooperation between Gangwon and Andhra Pradesh and to attend BioAsia 2013. The visit allowed an opportunity to reaffirm that both regions shared vision for economic development by promoting high-tech industry and concrete will for mutual cooperation. Moreover, a platform for future collaboration in Bio-Industry was established by signing MoU between APIIC and Gangwon Techno Park. Our entrepreneurs are also prospecting productive outcome from networking activities held in BioAsia 2013.
- Mr. Choi Moon-Soon, Hon’ble Governor of Gangwon Province, Republic of Korea - (@BioAsia 2013)
I would like to thank the organizers for the gracious hospitality which I enjoyed during my brief stay in Hyderabad. Indeed I had the opportunity to meet large number of people during the stimulating discussions. It has been a great experience to see what has been developed here and what is going on. We would be delighted to establish further collaborations with the organization. I enjoyed my participation at BioAsia very much. It has been very pleasant to meet many of the colleagues there and to enjoy the interesting program. I convey my gratitude and also my best wishes to the organizers.
- Prof. Dr. Harald zur Hausen, Nobel Laureate of Medicine, Former Scientific Director DKFZ, Germany - (@BioAsia 2014)
Dr. Reddy’s is very happy to be the co-host of the event. The pharmaceutical industry that I represent has done great service to not only the country but to the world particularly in making drugs affordable. And I am happy to state that the API revolution began in Andhra Pradesh which has mushroomed ever since as a result of which India has become the leading exporter of APIs, leading supplier of generics to the world and is also helping other countries around the world in bringing down their healthcare costs. The pharmaceutical industry has been a shining example of success in the country and I am happy that events like BioAsia that bring together academicians, industry, regulators to debate on important topics, strengthen the industry overall, strengthen the city, strengthen the economy and in a long term the impact on the economy is tremendous and that is why we are very happy to have supported the event and thank you for giving us this opportunity.
- Mr. GV Prasad, Chairman & CEO, Dr. Reddy’s Laboratories, India - (@BioAsia 2014)
I would like to thank the government of Andhra Pradesh and the organizers of BioAsia for bestowing the great honour of the Genome Valley Excellence Award on GSK for our leadership and progressive commitment to tropical disease. At GSK we are committed to tackling the root causes of disease and ill-health and to contributing to ensure healthier communities around the world. Neglected tropical diseases impact the lives of more than a billion people worldwide, and threaten the world’s most vulnerable populations and we are immensely proud to have received this award in recognition of our efforts against this public health challenge.
- Sir Andrew Witty, Chief Executive Officer, GSK, UK - (@BioAsia 2014)
I think it is great that people from all over the world come to India to discuss issues that we share and are important for bringing better healthcare to people around the world. It was really a privilege for me to be a part of this event and a great opportunity to become familiar with what we need to do in India.
- Dr. Bill Hait, Global Head R&D, Janssen Pharmaceutica (J&J), USA - (@BioAsia 2014)
It was a good experience for me to attend the BioAsia 2014, I enjoyed it very much. Due to my time limit, I only attended a few sessions. I feel that the panel sessions were organized well, the hosts were quite good and effective.
- Dr. Baoping Wang, President, Novo Nordisk Research Centre, China - (@BioAsia 2014)
GVK Biosciences has been a patron to BioAsia right from the beginning and has been sponsoring the event for several reasons, one is to encourage industry, science and government interaction and also we find a lot of value in interacting with various dignitaries that come here and conducting business discussions with them. We will continue to support BioAsia in the years to come in order to boost the ecosystem of innovation and interaction of various organizations. I appreciate all the efforts of the Government of Andhra Pradesh and FABA in bringing us all together. Congratulations to the organizers.
- Mr. Manni Kantipudi, CEO, GVK Biosciences, India - (@BioAsia 2014)
BioAsia over the years has been instrumental in showcasing the Lifesciences and R&D strengths of Hyderabad and Andhra Pradesh to the world particularly the presence of Genome Valley – the largest industrial cluster in country. India is an excellent destination for Biotech/Biopharma industries particularly Hyderabad, which has a strong base of pharma and biotech, specially vaccines. Almost 70% of the vaccine production in India is supplied from Hyderabad and this explains the focus of BioAsia on elements like policy, strategy and markets.